Evidence map›Paper›PMID 32981026›Full record

ArticleCEN case reports2021

Quetiapine-induced thrombotic microangiopathy in a patient on maintenance dialysis.

Miki Takahashi, Akihito Deguchi, Hiromu Nishihara, Mea Asou, Tomohiko Asakawa, Makoto Araki

Open access · greenAbstract readCase Reports
In one paragraph

Article in CEN case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Miki TakahashiDepartment of Internal Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino-shi, Nagano-ken, 391-8503, Japan.
Akihito DeguchiDepartment of Internal Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino-shi, Nagano-ken, 391-8503, Japan.
Hiromu NishiharaDepartment of Internal Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino-shi, Nagano-ken, 391-8503, Japan.
Mea AsouDepartment of Internal Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino-shi, Nagano-ken, 391-8503, Japan.
Tomohiko AsakawaDepartment of Internal Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino-shi, Nagano-ken, 391-8503, Japan.
Makoto ArakiDepartment of Internal Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino-shi, Nagano-ken, 391-8503, Japan. makoto.araki@gmail.com.ORCID 0000-0003-0854-4064
Suwa Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quetiapine has been reported to cause immune-mediated thrombotic microangiopathy (TMA), although few cases have been reported thus far. A 71-year-old man with autosomal dominant polycystic kidney disease on maintenance dialysis was hospitalized with a hemorrhagic basal ganglia stroke, and was treated with 25 mg quetiapine for delirium from day 4 of admission. There was no worsening of consciousness, fever, diarrhea, or elevated blood pressure during the hospitalization. Gingival bleeding appeared on day 35, and the platelet count on day 38 was 0.5 × 10

Indexed as

AgedHumansMalePolycystic Kidney, Autosomal DominantQuetiapine FumarateRenal DialysisThrombotic MicroangiopathiesQuetiapine FumarateADAMTS13HemodialysisQuetiapineThrombotic microangiopathy

Identifiers

PMID32981026
PMCPMC8019441
OpenAlexW3088081011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.